,i #aac? ,,congress #a/ ,session ,h4 ,r4 #hdb ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,febru>y #bf1 #bjac ,mr4 ,s5s5br5n] 7= himself & ,mr4 ,moran7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to exp& ! rese>* activities ( ! ,national ,in/itutes ( ,heal? ) respect to functional ga/ro9te/9al & motility disord]s1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,functional ,ga/ro9te/9al & ,motility ,disord]s ,rese>* ,enhancem5t ,act ( #bjac4 #b4 ,f9d+s ,congress f9ds ! foll[+3 7#a7 ,functional ga/ro9te/9al & motility disord]s 7,f,g,i,m,ds7 are *ronic conditions associat$ ) increas$ s5sitivity ( ! ,,gi tract1 abnormal motor function+1 & bra9-gut dysfunction4 7#b7 ,f,g,i,m,ds are *>act]iz$ by symptoms 9 ! ,,gi tract includ+ pa9 or discom=t1 nausea1 vomit+1 di>rhea1 con/ipation1 incont95ce1 problems 9 ! passage ( food or feces1 or a comb9ation ( ^! symptoms4 7#c7 ,f,g,i,m,ds include conditions su* z dysphagia1 ga/roesophageal reflux disease1 dyspepsia1 cyclic vomit+ syndrome1 ga/rop>esis1 irritable b[el syndrome 7,,ibs71 ,hirs*sprung's disease1 *ronic inte/9al pseudo-ob/ruction1 b[el incont95ce1 & _m o!rs1 :i* affect ! esophagus1 /oma*1 gallbladd]1 small & l>ge inte/9e1 & anorectal areas ( ! body4 7#d7 ,! sev]ity ( ,f,g,i,m,ds ranges f mildly uncom=table to debilitat+ & 9 "s cases life-?reat5+4 7#e7 ,effective treatm5ts = ! multiple symptoms ( ,f,g,i,m,ds are lack+1 & :ile suff]]s frequ5tly use a v>iety ( m$ications & !rapies = symptoms1 few pati5ts report satisfaction ) available treatm5ts4 7#f7 ,pati5ts ) ,f,g,i,m,ds frequ5tly suff] = ye>s be=e receiv+ an accurate diagnosis1 expos+ !m to unnecess>y & co/ly te/s & proc$ures includ+ surg]ies1 z well z ne$less suff]+ & exp5se4 7#g7 ,! economic impact ( ,f,g,i,m,ds is high4 ,! annual co/ 9 ! ,unit$ ,/ates = ,,ibs alone is e/imat$ to be betwe5 #a4g billion & #aj billion 9 direct m$ical co/s 7exclud+ prescription & ov]-!-c\nt] m$ications7 & #bj billion 9 indirect m$ical co/s4 7#h7 ,f,g,i,m,ds frequ5tly take a toll on ! workplace1 z reflect$ 9 "w abs5teeism1 lo/ productivity1 & lo/ opportunities = ! individual & society4 7#i7 ,ga/ro9te/9al symptoms consi/5t ) functional ga/ro9te/9al disord]s su* z ,,ibs & functional dyspepsia h be5 recogniz$ z a s]i\s & disabl+ issue = milit>y vet]ans1 p>ticul>ly ^? :o h be5 deploy$4 7#aj7 ,f,g,i,m,ds affect individuals ( all ages includ+ *ildr51 & p$iatric ,f,g,i,m,ds c be p>ticul>ly s]i\s1 lead+ to a lifetime ( pa9ful symptoms & m$ical exp5ses associat$ ) managem5t ( *ronic illness or dea?4 7#aa7 ,! ,national ,in/itutes ( ,heal?'s ,national ,commission on ,dige/ive ,diseases id5tifi$ compreh5sive rese>* goals relat$ to ,f,g,i,m,ds 9 its ,april #bjji report to ,congress & ! ,am]ican public entitl$ ,opportunities & ,*all5ges 9 ,dige/ive ,diseases ,rese>*3 ,recomm5dations ( ! ,national ,commission on ,dige/ive ,diseases4 #c4 ,functional ga/ro9te/9al & motility disord]s rese>* enhancem5t ,"p ,b ( title ,,iv ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bhd et seq47 is am5d$ by add+ at ! end ! foll[+3 #dji,k4 ,functional ga/ro9te/9al & motility disord]s ,! ,director ( ,,nih may exp&1 int5sify1 & coord9ate ! activities ( ! ,national ,in/itutes ( ,heal? ) respect to functional ga/ro9te/9al & motility disord]s 79 ?is section ref]r$ to z ,f,g,i,m,ds7 by-- 7#a7 exp&+ basic & cl9ical rese>* into ,f,g,i,m,ds by implem5t+ ! rese>* recomm5dations ( ! ,national ,commission on ,dige/ive ,diseases relat+ to ,f,g,i,m,ds2 7#b7 provid+ support = ! e/abli%m5t ( up to five c5t]s ( excell5ce on ,f,g,i,m,ds at lead+ academic m$ical c5t]s ?r\gh\t ! c\ntry to c>ry out innovative basic1 translational1 & cl9ical rese>* focus$ on ,f,g,i,m,ds2 7#c7 explor+ collaborative rese>* opportunities among ! ,national ,in/itute ( ,diabetes & ,dige/ive & ,kidney ,diseases1 ! ,(fice ( ,rese>* on ,wom5's ,heal?1 ! ,(fice ( ,r>e ,disease ,rese>*1 & o!r ,in/itutes & ,c5t]s ( ! ,national ,in/itutes ( ,heal?2 7#d7 direct+ ! ,national ,in/itute ( ,diabetes & ,dige/ive & ,kidney ,diseases to provide ! necess>y fund+ = cont9u$ expansion & advancem5t ( ! ,f,g,i,m,ds rese>* portfolio ?r\gh intramural & extramural rese>*2 7#e7 direct+ ! ,national ,in/itute ( ,diabetes & ,dige/ive & ,kidney ,diseases & ! ,eunice ,k5n$y ,%riv] ,national ,in/itute ( ,*ild ,heal? & ,human ,developm5t to exp& rese>* into ,f,g,i,m,ds t impact *ildr51 su* z ,hirs*sprung's disease & cyclic vomit+ syndrome1 & mat]nal heal?1 su* z fecal incont95ce2 & 7#f7 explor+ opportunities to p>tn] ) ! ,dep>tm5t ( ,def5se & ! ,dep>tm5t ( ,vet]ans ,affairs to increase rese>* & improve pati5t c>e reg>d+ ,f,g,i,m,ds t commonly impact vet]ans & active duty milit>y p]sonnel1 su* z ,,ibs & dyspepsia4 4 #d4 ,promot+ public aw>5ess ( functional ga/ro9te/9al & motility disord]s ,"p ,b ( title ,,iii ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bdc et seq47 is am5d$ by add+ at ! end ! foll[+3 #cbj;,b4 ,public aw>5ess ( functional ga/ro9te/9al & motility disord]s ,! ,secret>y may engage 9 public aw>5ess & education activities to increase und]/&+ & recognition ( functional ga/ro9te/9al & motility disord]s 79 ?is section ref]r$ to z ,f,g,i,m,ds74 ,su* activities may include ! di/ribution ( pr9t1 film1 & web-bas$ mat]ials t>get+ heal? c>e provid]s & ! public & prep>$ & dissem9at$ 9 conjunction ) pati5t organizations t treat ,f,g,i,m,ds4 ,! in=mation express$ ?r\gh su* activites %\ld emphasize-- 7#a7 basic in=mation on ,f,g,i,m,ds1 _! symptoms1 preval5ce1 & frequ5tly co-occurr+ conditions2 & 7#b7 ! importance ( e>ly diagnosis1 & prompt & accurate treatm5t ( ,f,g,i,m,ds4 4 #e4 ,s5se ( ,congress on ! developm5t & ov]sight ( innovative treatm5t options = functional ga/ro9te/9al & motility disord]s ,x is ! s5se ( ,congress t1 consid]+ ! curr5t lack ( effective treatm5t options = ! global symptoms ( functional ga/ro9te/9al & motility disord]s 79 ?is section ref]r$ to z ,f,g,i,m,ds7 & ! inh]5t *all5ges ( develop+ & br++ su* treatm5ts to m>ket1 ! ,commission] ( ,food & ,drugs %\ld cont9ue & accel]ate important ef=ts to improve ! developm5t & ov]sight ( treatm5t options = ,f,g,i,m,ds by-- 7#a7 enhanc+ ! commitm5t to em]g+ ef=ts l ! ,pati5t ,report$ ,outcomes ,consortium to exp$ite m$ical device & drug developm5t1 /udy appropriate balances betwe5 risk & pati5t b5efit1 & id5tify prop] endpo9ts = conditions )\t cle>1 biological indicators2 7#b7 enhanc+ ! commitm5t to broad ef=ts l ! ,critical ,pa? ,initiative focus$ on ensur+ t sci5tific break?r\ghs are quickly translat$ into safe & b5eficial treatm5t options2 & 7#c7 cont9u+ collaboration ) pati5t organizations t treat ,f,g,i,m,ds s t ! pati5t p]spective is consid]$ :5 det]m9+ ! ne$ = innovative treatm5ts4